The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohns disease in a Danish case-control study

BMC Medical Genetics

Volumn 11, Issue 1, 2010, Pages

  Andersen, Vibeke ^a   Ernst, Anja ^c   Christensen, Jane ^b   Østergaard, Mette ^a   Jacobsen, Bent A ^c   Tjønneland, Anne ^b   Krarup, Henrik B ^c   Vogel, Ulla ^d,e,f  

^a VIBORG HOSPITAL   (Denmark)

^b INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^e ROSKILDE UNIVERSITY   (Denmark)

^f NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

HEME OXYGENASE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 1;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CROHN DISEASE; DENMARK; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; ULCERATIVE COLITIS; CONFIDENCE INTERVAL; GENETICS; GENOTYPE; RISK; RISK FACTOR; STATISTICAL MODEL;

CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CONFIDENCE INTERVALS; CROHN DISEASE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEME OXYGENASE-1; HUMANS; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-1BETA; LOGISTIC MODELS; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 77952704894     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-11-82     Document Type: Article

References (65)

1. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007, 448:427-434. 10.1038/nature06005, 17653185.
2. Franke A, Balschun T, Karlsen TH, Hedderich J, May S, Lu T, et al. Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nat Genet 2008, 40:713-715. 10.1038/ng.148, 18438405.
3. Ernst A, Jacobsen B, Ostergaard M, Okkels H, Andersen V, Dagiliene E, et al. Mutations in CARD15 and smoking confer susceptibility to Crohn's disease in the Danish population. Scand J Gastroenterol 2007, 42:1445-1451. 10.1080/00365520701427102, 17852840.
4. Hindorff LA, Junkins HA, Manolio TA. A Catalog of Published Genome-Wide Association Studies A Catalog of Published Genome-Wide Association Studies. 2008, Accessed [20Feb2010], A Catalog of Published Genome-Wide Association Studies., http://www.genome.gov/26525384
5. Ostergaard M, Ernst A, Labouriau R, Dagiliene E, Krarup HB, Christensen M, et al. Cyclooxygenase-2, multidrug resistance 1, and breast cancer resistance protein gene polymorphisms and inflammatory bowel disease in the Danish population. Scand J Gastroenterol 2009, 44:65-73. 10.1080/00365520802400826, 18819034.
6. Fisher SA, Tremelling M, Anderson CA, Gwilliam R, Bumpstead S, Prescott NJ, et al. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat Genet 2008, 40:710-712. 10.1038/ng.145, 2719289, 18438406.
7. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008, 40:955-962. 10.1038/ng.175, 2574810, 18587394.
8. Duerr RH. Update on the genetics of inflammatory bowel disease. J Clin Gastroenterol 2003, 37:358-367. 10.1097/00004836-200311000-00003, 14564181.
9. Brant SR, Shugart YY. Inflammatory bowel disease gene hunting by linkage analysis: rationale, methodology, and present status of the field. Inflamm Bowel Dis 2004, 10:300-311. 10.1097/00054725-200405000-00019, 15290927.
10. Hugot JP, Zaccaria I, Cavanaugh J, Yang H, Vermeire S, Lappalainen M, et al. Prevalence of CARD15/NOD2 mutations in Caucasian healthy people. Am J Gastroenterol 2007, 102:1259-1267. 10.1111/j.1572-0241.2007.01149.x, 17319929.
11. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet 2007, 369:1627-1640. 10.1016/S0140-6736(07)60750-8, 17499605.
12. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 2007, 117:514-521. 10.1172/JCI30587, 1804356, 17332878.
13. Fukata M, Abreu MT. What Are Toll-like Receptors and what Role May They Have in IBD. Inflamm Bowel Dis 2008, 14:S90-S91. 10.1002/ibd.20632, 18816733.
14. Werner T, Haller D. Intestinal epithelial cell signalling and chronic inflammation: From the proteome to specific molecular mechanisms. Mutat Res 2007, 622:42-57.
15. Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 2009, 27(519-50):519-550. 10.1146/annurev.immunol.021908.132612, 19302047.
16. Guimbaud R, Bertrand V, Chauvelot-Moachon L, Quartier G, Vidon N, Giroud JP, et al. Network of inflammatory cytokines and correlation with disease activity in ulcerative colitis. Am J Gastroenterol 1998, 93:2397-2404. 10.1111/j.1572-0241.1998.00694.x, 9860399.
17. Kidd M, Gustafsson BI, Drozdov I, Modlin IM. IL1beta- and LPS-induced serotonin secretion is increased in EC cells derived from Crohn's disease. Neurogastroenterol Motil 2009, 21:439-450. 10.1111/j.1365-2982.2008.01210.x, 19019013.
18. Chen H, Wilkins LM, Aziz N, Cannings C, Wyllie DH, Bingle C, et al. Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet 2006, 15:519-529. 10.1093/hmg/ddi469, 16399797.
19. Hacker UT, Bidlingmaier C, Gomolka M, Keller E, Eigler A, Hartmann G, et al. Inflammatory bowel disease: no association between allele combinations of the interleukin (IL) I beta and IL-I receptor antagonist gene polymorphisms. Eur J Clin Invest 1998, 28:214-219. 10.1046/j.1365-2362.1998.00277.x, 9568467.
20. Corleto VD, Pagnini C, Margagnoni G, Guagnozzi D, Torre MS, Martorelli M, et al. IL-1beta-511 and IL-1RN*2 polymorphisms in inflammatory bowel disease: An Italian population study and meta-analysis of European studies. Dig Liver Dis 2010, 42:179-84. 10.1016/j.dld.2009.06.016, 19643686.
21. Ferreira AC, Almeida S, Tavares M, Canedo P, Pereira F, Regalo G, et al. NOD2/CARD15 and TNFA, but not IL1B and IL1RN, are associated with Crohn's disease. Inflamm Bowel Dis 2005, 11:331-339. 10.1097/01.MIB.0000158153.71579.b4, 15803022.
22. Balding J, Livingstone WJ, Conroy J, Mynett-Johnson L, Weir DG, Mahmud N, et al. Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms. Mediators Inflamm 2004, 13:181-187. 10.1080/09511920410001713529, 1781555, 15223609.
23. Stokkers PC, van Aken BE, Basoski N, Reitsma PH, Tytgat GN, van Deventer SJ. Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease. Gut 1998, 43:33-39. 1727194, 9771403.
24. Queiroz DM, Oliveira AG, Saraiva IE, Rocha GA, Rocha AM, das Gracas Pimenta SM, et al. Immune response and gene polymorphism profiles in Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2009, 15:353-358. 10.1002/ibd.20757, 18942754.
25. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993, 75:263-274. 10.1016/0092-8674(93)80068-P, 8402911.
26. Ishizuka K, Sugimura K, Homma T, Matsuzawa J, Mochizuki T, Kobayashi M, et al. Influence of interleukin-10 on the interleukin-1 receptor antagonist/interleukin-1 beta ratio in the colonic mucosa of ulcerative colitis. Digestion 2001, 63(Suppl 1):22-7-22-27.
27. Correa I, Veny M, Esteller M, Pique JM, Yague J, Panes J, et al. Defective IL-10 production in severe phenotypes of Crohn's disease. J Leukoc Biol 2009, 85:896-903. 10.1189/jlb.1108698, 19237638.
28. Schreiber S, Heinig T, Thiele HG, Raedler A. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology 1995, 108:1434-1444. 10.1016/0016-5085(95)90692-4, 7729636.
29. Franke A, Balschun T, Karlsen TH, Sventoraityte J, Nikolaus S, Mayr G, et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet 2008, 40:1319-1323. 10.1038/ng.221, 18836448.
30. Amre DK, Mack DR, Morgan K, Israel D, Lambrette P, Costea I, et al. Interleukin 10 (IL-10) gene variants and susceptibility for paediatric onset Crohn's disease. Aliment Pharmacol Ther 2009, 29:1025-1031. 10.1111/j.1365-2036.2009.03953.x, 19210299.
31. Koss K, Satsangi J, Fanning GC, Welsh KI, Jewell DP. Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies. Genes Immun 2000, 1:185-190. 10.1038/sj.gene.6363657, 11196710.
32. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997, 24:1-8.
33. Ouma C, Davenport GC, Were T, Otieno MF, Hittner JB, Vulule JM, et al. Haplotypes of IL-10 promoter variants are associated with susceptibility to severe malarial anemia and functional changes in IL-10 production. Hum Genet 2008, 124:515-524. 10.1007/s00439-008-0578-5, 2723852, 18972133.
34. Shin HD, Winkler C, Stephens JC, Bream J, Young H, Goedert JJ, et al. Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc Natl Acad Sci USA 2000, 19(97):14467-14472.
35. Fowler EV, Eri R, Hume G, Johnstone S, Pandeya N, Lincoln D, et al. TNFalpha and IL10 SNPs act together to predict disease behaviour in Crohn's disease. J Med Genet 2005, 42:523-528. 10.1136/jmg.2004.027425, 1736076, 15937090.
36. Tedde A, Laura PA, Bagnoli S, Congregati C, Milla M, Sorbi S, et al. Interleukin-10 promoter polymorphisms influence susceptibility to ulcerative colitis in a gender-specific manner. Scand J Gastroenterol 2008, 43:712-718. 10.1080/00365520701885507, 18569989.
37. Tagore A, Gonsalkorale WM, Pravica V, Hajeer AH, McMahon R, Whorwell PJ, et al. Interleukin-10 (IL-10) genotypes in inflammatory bowel disease. Tissue Antigens 1999, 54:386-390. 10.1034/j.1399-0039.1999.540408.x, 10551422.
38. Fernandez L, Martinez A, Mendoza JL, Urcelay E, Fernandez-Arquero M, Garcia-Paredes J, et al. Interleukin-10 polymorphisms in Spanish patients with IBD. Inflamm Bowel Dis 2005, 11:739-743. 10.1097/01.MIB.0000173457.64868.20, 16043989.
39. Parkes M, Satsangi J, Jewell D. Contribution of the IL-2 and IL-10 genes to inflammatory bowel disease (IBD) susceptibility. Clin Exp Immunol 1998, 113:28-32. 10.1046/j.1365-2249.1998.00625.x, 1905008, 9697979.
40. Klein W, Tromm A, Griga T, Fricke H, Folwaczny C, Hocke M, et al. The IL-10 gene is not involved in the predisposition to inflammatory bowel disease. Electrophoresis 2000, 21:3578-3582. 10.1002/1522-2683(200011)21:17<3578::AID-ELPS3578>3.0.CO;2-Z, 11271474.
41. Pae HO, Kim EC, Chung HT. Integrative survival response evoked by heme oxygenase-1 and heme metabolites. J Clin Biochem Nutr 2008, 42:197-203. 10.3164/jcbn.2008029, 2386522, 18545641.
42. Lee TS, Chau LY. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 2002, 8:240-246. 10.1038/nm0302-240, 11875494.
43. Berberat PO, Rahim YI, Yamashita K, Warny MM, Csizmadia E, Robson SC, et al. Heme oxygenase-1-generated biliverdin ameliorates experimental murine colitis. Inflamm Bowel Dis 2005, 11:350-359. 10.1097/01.MIB.0000164017.06538.8a, 15803024.
44. Paul G, Bataille F, Obermeier F, Bock J, Klebl F, Strauch U, et al. Analysis of intestinal haem-oxygenase-1 (HO-1) in clinical and experimental colitis. Clin Exp Immunol 2005, 140:547-555. 10.1111/j.1365-2249.2005.02775.x, 1809385, 15932518.
45. Wang WP, Guo X, Koo MW, Wong BC, Lam SK, Ye YN, et al. Protective role of heme oxygenase-1 on trinitrobenzene sulfonic acid-induced colitis in rats. Am J Physiol Gastrointest Liver Physiol 2001, 281:G586-G594.
46. Hegazi RA, Rao KN, Mayle A, Sepulveda AR, Otterbein LE, Plevy SE. Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway. J Exp Med 2005, 19(202):1703-1713.
47. Takagi T, Naito Y, Mizushima K, Nukigi Y, Okada H, Suzuki T, et al. Increased intestinal expression of heme oxygenase-1 and its localization in patients with ulcerative colitis. J Gastroenterol Hepatol 2008, 23(Suppl 2):S229-S233. 10.1111/j.1440-1746.2008.05443.x, 19120903.
48. Ono K, Goto Y, Takagi S, Baba S, Tago N, Nonogi H, et al. A promoter variant of the heme oxygenase-1 gene may reduce the incidence of ischemic heart disease in Japanese. Atherosclerosis 2004, 173:315-319. 10.1016/j.atherosclerosis.2003.11.021, 15064108.
49. Hausmann M, Paul G, Kellermeier S, Frey I, Scholmerich J, Falk W, et al. (GT)N dinucleotide repeat polymorphism of haem oxygenase-1 promotor region is not associated with inflammatory bowel disease risk or disease course. Clin Exp Immunol 2008, 153:81-85. 10.1111/j.1365-2249.2008.03674.x, 2432101, 18460015.
50. Mahid SS, Minor KS, Soto RE, Hornung CA, Galandiuk S. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc 2006, 81:1462-1471. 10.4065/81.11.1462, 17120402.
51. Kikuchi H, Itoh J, Fukuda S. Chronic nicotine stimulation modulates the immune response of mucosal T cells to Th1-dominant pattern via nAChR by upregulation of Th1-specific transcriptional factor. Neurosci Lett 2008, 432:217-221. 10.1016/j.neulet.2007.12.027, 18248893.
52. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002, 347:417-429. 10.1056/NEJMra020831, 12167685.
53. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006, 55:749-753. 10.1136/gut.2005.082909, 1856208, 16698746.
54. Macarthur M, Sharp L, Hold GL, Little J, El-Omar EM. The role of cytokine gene polymorphisms in colorectal cancer and their interaction with aspirin use in the northeast of Scotland. Cancer Epidemiol Biomarkers Prev 2005, 14:1613-1618. 10.1158/1055-9965.EPI-04-0878, 16030091.
55. Vogel U, Christensen J, Wallin H, Friis S, Nexo BA, Tjonneland A. Polymorphisms in COX-2, NSAID use and risk of basal cell carcinoma in a prospective study of Danes. Mutat Res 2007, 617:138-146.
56. Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology 1995, 6:356-365. 10.1097/00001648-199507000-00005, 7548341.
57. Genetic Power Calculator. 2009, , http://pngu.mgh.harvard.edu/~purcell/gpc/cc2.html
58. Tedde A, Laura PA, Bagnoli S, Congregati C, Milla M, Sorbi S, et al. Interleukin-10 promoter polymorphisms influence susceptibility to ulcerative colitis in a gender-specific manner. Scand J Gastroenterol 2008, 43:712-718. 10.1080/00365520701885507, 18569989.
59. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000, 404:398-402. 10.1038/35006081, 10746728.
60. Vogel U, Christensen J, Wallin H, Friis S, Nexo BA, Raaschou-Nielsen O, et al. Polymorphisms in genes involved in the inflammatory response and interaction with NSAID use or smoking in relation to lung cancer risk in a prospective study. Mutat Res 2008, 639:89-100.
61. Birrenbach T, Bocker U. Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications. Inflamm Bowel Dis 2004, 10:848-859. 10.1097/00054725-200411000-00019, 15626903.
62. Aldhous MC, Prescott RJ, Roberts S, Samuel K, Waterfall M, Satsangi J. Does nicotine influence cytokine profile and subsequent cell cycling/apoptotic responses in inflammatory bowel disease?. Inflamm Bowel Dis 2008, 14:1469-1482. 10.1002/ibd.20523, 18618634.
63. Karban A, Eliakim R. Effect of smoking on inflammatory bowel disease: Is it disease or organ specific?. World J Gastroenterol 2007, 13:2150-2152.
64. Fowler EV, Doecke J, Simms LA, Zhao ZZ, Webb PM, Hayward NK, et al. ATG16L1 T300A shows strong associations with disease subgroups in a large Australian IBD population: further support for significant disease heterogeneity. Am J Gastroenterol 2008, 103:2519-2526. 10.1111/j.1572-0241.2008.02023.x, 18671817.
65. Achkar JP, Dassopoulos T, Silverberg MS, Tuvlin JA, Duerr RH, Brant SR, et al. Phenotype-stratified genetic linkage study demonstrates that IBD2 is an extensive ulcerative colitis locus. Am J Gastroenterol 2006, 101:572-580. 10.1111/j.1572-0241.2006.00451.x, 16542294.